Rani Therapeutics Holdings (RANI) EPS (Basic) (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly EPS (Basic) of -$0.06 for Q1 2026, up 84.9% year-over-year from -$0.03 in Q1 2025, and up 99.96% quarter-over-quarter from -$130.44 in Q4 2025.
Rani Therapeutics Holdings (RANI) EPS (Basic) (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.06 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 84.9% year-over-year to -$0.06; the TTM figure through Mar 2026 stood at -$0.23 (up 86.09% YoY), while the FY2025 annual figure was -$1762.1, up 11.32% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.06, up from -$130.44 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.06 in Q1 2026, with the low at -$729.39 in Q4 2022.
- The 5-year median for EPS (Basic) is -$0.66 (2022), against an average of -$108.53.
- The sharpest annual moves came in 2022 and 2026: EPS (Basic) tumbled 106987.57% in 2022, then jumped 84.9% in 2026.
- Rani Therapeutics Holdings' EPS (Basic) stood at -$729.39 in 2022, then grew by 24.45% to -$551.07 in 2023, then rose by 22.45% to -$427.34 in 2024, then jumped by 69.48% to -$130.44 in 2025, then soared by 99.96% to -$0.06 in 2026.
- Business Quant data shows RANI's EPS (Basic) at -$0.06 in Q1 2026, -$130.44 in Q4 2025, and -$0.26 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - | 0.18 |
| 10 | Rani Therapeutics Holdings | 165.62 Mn | 165.62 Mn | - | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.07 |
| Mar 31, 2026 | -0.06 |
| Dec 31, 2025 | -130.44 |
| Sep 30, 2025 | -0.26 |
| Jun 30, 2025 | -0.31 |
| Mar 31, 2025 | -0.38 |
| Dec 31, 2024 | -427.34 |
| Sep 30, 2024 | -0.63 |
| Jun 30, 2024 | -0.51 |
| Mar 31, 2024 | -0.57 |
| Dec 31, 2023 | -551.07 |
| Sep 30, 2023 | -0.72 |
| Jun 30, 2023 | -0.74 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -729.39 |
| Sep 30, 2022 | -0.66 |
| Jun 30, 2022 | -0.66 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | -0.68 |
| Sep 30, 2021 | -1.48 |